Trials / Conditions / Chronic Graft-versus-host Disease (cGVHD)
Chronic Graft-versus-host Disease (cGVHD)
5 registered clinical trials studyying Chronic Graft-versus-host Disease (cGVHD) — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Ruxolitinib vs Prednisone as First-line Therapy for cGVHD Needing Systemic Therapy NCT06660355 | H. Lee Moffitt Cancer Center and Research Institute | Phase 2 |
| Recruiting | A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD) NCT06619561 | Deciphera Pharmaceuticals, LLC | Phase 2 |
| Completed | A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of AMG 592 in Healthy Japanese Participants NCT05885451 | Amgen | Phase 1 |
| Terminated | Safety and Efficacy of Efavaleukin Alfa in Subjects With Steroid Refractory Chronic Graft Versus Host Disease NCT03422627 | Amgen | Phase 1 / Phase 2 |
| Completed | A Study to Evaluate the Safety, Tolerability, Immunogenicity, Pharmacokinetics, and Pharmacodynamics of AMG 59 NCT05873907 | Amgen | Phase 1 |